Schedule F Is Coming for Federal Grant Makers. The Consequences for American Science Could Last a Generation.

The people who decide which scientists receive federal funding are, by design, invisible. They are the program officers at NIH who manage portfolios of hundreds of grants. They are the reviewers at NSF who evaluate thousands of proposals each cycle. They are the career civil servants at DOE, DOD, and USDA who translate congressional appropriations into individual awards. For decades, their anonymity has been a feature, not a bug — a structural protection that allows scientific merit, rather than political alignment, to determine where billions of research dollars flow.

That protection is now being dismantled. (Granted News)

The Office of Personnel Management's Schedule Policy/Career rule — the formal name for what most people still call Schedule F — took effect in March 2026, creating a new employment category that strips civil service protections from federal workers in "policy-influencing" positions. OPM estimates 50,000 positions will be affected. The Association of American Medical Colleges believes the actual number could be four times higher. Neither figure accounts for the behavioral changes that will ripple through every agency long before a single employee is fired.

What Schedule F Actually Does

The mechanics are straightforward. Under the traditional civil service system, career federal employees can only be fired for cause — documented poor performance or misconduct — and have the right to appeal their termination to the Merit Systems Protection Board. Schedule Policy/Career eliminates both protections. Reclassified employees become at-will workers who can be terminated without explanation and without recourse.

The rule also strips converted employees of access to the Office of Special Counsel's whistleblower protections, eligibility for recruitment and retention incentives, student loan repayment programs, and Presidential Rank Awards. These are not abstract benefits. They are the tools the federal government uses to attract and retain the specialized talent — epidemiologists, nuclear physicists, climate scientists, artificial intelligence researchers — who cannot be replaced by political appointees with two-year tenures.

OPM has stated that positions involved in "scientific grantmaking" that "influence public policy" are "appropriate candidates" for reclassification. This language is broad enough to encompass virtually every program officer, grants management specialist, and scientific review officer at every federal funding agency. The rule's defenders argue that purely technical positions without policy influence will remain protected. Its critics note that "policy influence" in the context of scientific grantmaking is an almost meaningless distinction — every decision about which research to fund is, by definition, a decision about which scientific questions the government considers worth answering.

The Grant-Making Chain of Command

To understand what Schedule F means for the research enterprise, you need to understand how federal grants actually work. The process involves a chain of career officials whose independent judgment is the system's core quality control mechanism.

Scientific review officers organize and manage peer review panels — the study sections at NIH, the review committees at NSF, the evaluation boards at DOE. These officials select reviewers, manage conflicts of interest, and ensure that panels evaluate proposals on scientific merit rather than institutional prestige or political palatability.

Program officers manage portfolios of funded grants and make recommendations about which proposals to fund from among those the peer review panels have scored favorably. At NIH, program officers have significant discretion in assembling funding slates — the final list of proposals recommended for awards within a given budget cycle. That discretion is exercised within boundaries set by institute directors and advisory councils, but the day-to-day judgment calls about which promising proposals make the cut are made by career staff.

Grants management specialists handle the administrative and compliance dimensions of federal awards — budget negotiations, no-cost extensions, carryover requests, and audit responses. These positions might seem purely clerical, but they exercise substantial judgment in interpreting federal regulations. A grants management specialist who approves a budget modification is making a decision that can determine whether a three-year research project reaches completion or runs out of money twelve months early.

Every link in this chain currently operates under civil service protections that insulate individual decisions from political pressure. Schedule F removes that insulation for any position that OPM and agency heads determine is "policy-influencing."

The Chilling Effect Is Already Happening

The most consequential impact of Schedule F may not be the firings that follow reclassification. It may be the self-censorship that precedes them.

NIH grant reviewers told STAT News in February that the prospect of Schedule F classification is already changing how they approach their work. The fear is not abstract: program officers watched as the administration terminated thousands of NIH grants in 2025, with the agency awarding 5,564 fewer grants in fiscal year 2025 than in 2024 — an 8.6 percent drop. Women and early-career scientists bore a disproportionate share of those cuts. The message received by career staff was unambiguous: funding decisions that conflict with administration priorities carry professional risk.

Under Schedule F, that risk becomes existential. A program officer who champions a climate change research portfolio, an infectious disease preparedness study, or a health equity initiative does so knowing that the same decision could be cited as evidence of "policy influence" justifying reclassification — and that reclassification removes every procedural protection against termination.

The result is a system where the most consequential decisions — which proposals to prioritize, which research directions to encourage, which investigators to support — will increasingly be shaped by what career officials believe is politically safe rather than what they believe is scientifically important.

NIH: Ground Zero

The National Institutes of Health is the clearest case study of what Schedule F means in practice, because NIH is already operating under extraordinary pressure. As of March 3, the agency had distributed 74 percent fewer competitive awards than the average for the same period in fiscal years 2021 through 2024. The AAMC reported on March 25 that NIH has only obligated approximately 15 percent of the estimated $38 billion it has available for grants and contracts — a staggering slowdown that is already forcing labs to furlough staff, delay experiments, and shelve projects that took years to develop.

Into this environment, Schedule F introduces a new variable: the knowledge that the program officers managing this diminished funding pipeline can be fired at will if their decisions are perceived as politically inconvenient. The combination of less money and less job security creates a double bind that the American research enterprise has never faced before.

The implications extend beyond NIH's own workforce. Universities and research institutions depend on the predictability and political independence of federal grant-making to plan multi-year research programs, recruit faculty, and train graduate students. When a program officer can be fired for championing the wrong research area, the entire ecosystem of institutions that depend on federal funding must recalibrate their own risk tolerance.

The Legal Battle

A coalition including federal employee unions, the Citizens for Responsibility and Ethics in Washington, and Democracy Forward has sued to block Schedule F's implementation, arguing that it violates constitutional due process protections and exceeds presidential authority over the civil service. The legal challenge faces an uncertain path through a judiciary that has, in recent years, shown increasing deference to executive authority over federal workforce management.

The 94 percent opposition rate among the more than 40,500 public comments OPM received on the rule is a striking indicator of expert opinion, though public comment has limited legal weight. The American Federation of Government Employees warned of a "chilling effect" that extends far beyond the individuals who are actually reclassified. Partnership for Public Service CEO Max Stier characterized the changes as producing "worse, incompetent and even more corrupt government."

The legal outcome matters, but even a successful challenge will not undo the behavioral changes already underway. Career officials who have spent months contemplating the loss of their job protections do not immediately resume independent judgment the day a court issues a stay. The uncertainty itself is a form of pressure.

What This Means for Grant Seekers

If you are a researcher, nonprofit leader, or small business founder who depends on federal grants, Schedule F has concrete implications for your strategy.

Expect narrower funding priorities. As career grant-making officials become more risk-averse, funding decisions will increasingly cluster around research areas that align with stated administration priorities. For fiscal year 2026, those priorities include artificial intelligence, critical minerals, defense technology, fossil energy, infrastructure, and workforce development. Research areas that are politically neutral or aligned with these priorities will face less friction. Research areas that can be characterized as politically controversial — regardless of their scientific merit — will face more.

Build relationships early and broadly. The value of relationships with individual program officers increases in an environment where those officers may be reassigned or replaced. Researchers who have cultivated connections across multiple agencies and program areas are better insulated than those who depend on a single program officer or a single funding stream.

Diversify your funding portfolio. The instability in federal grant-making makes diversification from federal funding more important than it has been in decades. Private foundations, state grant programs, and industry partnerships cannot replace NIH or NSF at scale, but they can provide the bridge funding that keeps a lab operational during periods of federal uncertainty. The OpenAI Foundation's $1 billion grant pledge is one example of private capital entering spaces that federal funding may be vacating.

Document everything. In an environment where grant-making decisions may be subject to political review, meticulous documentation of how you use federal funds is more important than ever. Compliance that was adequate under a stable civil service may be scrutinized more closely by political appointees who lack the institutional knowledge that career staff provided.

The Deeper Stakes

The United States built the world's most productive research enterprise on a simple institutional design: elected officials set broad priorities and funding levels, career civil servants translate those priorities into specific awards, and the merit review system ensures that the best science gets funded regardless of who is in the White House. Schedule F does not merely weaken this design. It replaces it with a system in which every link in the grant-making chain operates under the knowledge that political alignment, not just scientific merit, determines their professional survival.

That system will still fund research. Grants will still be made. Scientists will still submit proposals. But the research that gets funded — and more importantly, the research that does not — will reflect a different set of priorities. And the career scientists who once served as the system's institutional memory and quality control will increasingly be replaced by officials whose primary qualification is political reliability.

For anyone building a career in science or a business around federal funding, the strategic response is the same: widen your search, diversify your sources, and build the kind of proposal that succeeds on its merits across multiple funding environments. Tools like Granted exist precisely for moments like this — when the funding landscape shifts and the researchers who adapt fastest are the ones who keep their programs alive.